A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Email
Print
Home > Medical Reference > Patient Education
Ask the Expert
Get answers to your Gamma Knife questions.
Related Content
- Gamma Knife Center
- Brain Tumor Center
- Brain Tumor-related Cancer Overviews
- Patient Success Stories
- Our Doctors
Brain tumors - primary - Highlights
- Highlights
- Introduction
- Causes
- Risk Factors
- Prognosis
- Symptoms
- Diagnosis
- Treatment
- Surgery
- Radiation
- Chemotherapy
- Treatment of Complications
Description
An in-depth report on the causes, diagnosis, and treatment of brain tumors.Alternative Names
Gliomas; Medulloblastomas
Highlights:
Primary Brain Tumors
Primary brain tumors are tumors that start in the brain. There are many types and subtypes of primary brain tumors. They include gliomas (which include astrocytomas, oligodendrogliomas, and ependydomas), meningomas, medullablastomas, pituitary adenomas, and central nervous system lymphomas.
Causes
The exact causes of primary brain tumors are unknown. Genetic factors and inherited disorders play a role in some types of brain tumors.
Risk Factors
Risk factors for brain tumors vary according to the type of tumor. Some types of tumors are more prevalent in men than in women. Some types of brain tumors usually occur in children, while others are more common in older people.
Prognosis
Survival rates in people with brain tumors depend on many different variables:
- Type of tumor
- Location and size of tumor (these factors affect whether the tumor can be removed surgically or not)
- Tumor grade
- Patient's age
- Patient's ability to function
- How far the tumor has spread
Symptoms
Brain tumors produce a variety of symptoms, including headache, seizure, and neurological changes. Symptoms may be subtle and gradually become worse or they may occur very rapidly.
Diagnosis
Diagnosis of brain tumors involves a neurological exam and various types of imaging tests. Imaging techniques include magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) scan. Biopsies may be performed as part of surgery to remove a tumor, or as a separate diagnostic procedure.
Treatment
The standard approach for treating brain tumors is to reduce the tumor as much as possible using surgery, radiation treatment, or chemotherapy. Such treatments are typically used in combination with each other.
Resources
- www.abta.org -- American Brain Tumor Association
- www.cbtf.org -- Children's Brain Tumor Foundation
- www.virtualtrials.com -- Musella Foundation for Brain Tumor Research and Information
- www.braintumor.org -- National Brain Tumor Society
- www.neurosurgery.org -- American Association of Neurologic Surgeons
- www.cancer.org -- American Cancer Society
- www.cancer.gov -- National Cancer Institute
- www.asco.org -- American Society for Clinical Oncology
- www.cancer.gov/clinicaltrials -- Find clinical trials
- www.radiologyinfo.org -- RadiologyInfo
- www.cancer.net -- Cancer.Net
References
Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006 Nov 20;24(33):5277-82. Epub 2006 Nov 6.
Buckner JC, Brown PD, O'Neill BP, Meyer FB, Wetmore CJ, Uhm JH. Central nervous system tumors. Mayo Clin Proc. 2007 Oct;82(10):1271-86.
Chandana SR, Movva S, Arora M, Singh T. Primary brain tumors in adults. Am Fam Physician. 2008 May 15;77(10):1423-30.
Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al. Long-term survival with glioblastoma multiforme. Brain. 2007 Oct;130(Pt 10):2596-606. Epub 2007 Sep 4.
Nathan PC, Patel SK, Dilley K, Goldsby R, Harvey J, Jacobsen C, et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med. 2007 Aug;161(8):798-806.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Central nervous system cancers. V.1.2008
Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006 Nov 1;98(21):1528-37.
Norden AD, Young GS, Setayesh K, Muzikansky A, Klufas R, Ross GL, et al.Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology. 2008 Mar 4;70(10):779-87.
Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Molecularly targeted therapy for malignant glioma. Cancer. 2007 Jul 1;110(1):13-24.
Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008 Jul 31;359(5):492-507.
- Reviewed last on: 12/5/2008
- Harvey Simon, MD, Editor-in-Chief, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
Click to Print
Print Preview
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885
